Common Side Effects Reported Across Phase 2 trials, participants experienced dose-dependent GI symptoms that are characteristic of GLP-1 receptor agonists: Nausea most frequent, especially during dose escalation Vomiting typically mild to moderate, subsiding with continued use Diarrhea and constipation fluctuating depending on individual tolerance Abdominal discomfort transient and often improved over time Dose-Response Relationship At lower doses (14 mg weekly), side effects were generally mild and manageable, though some participants still reported early GI symptoms
Your provider should order lab work, thoroughly review your medical history, and complete a BMI evaluation
As a food supplement rather than a licensed medicine, berberine products are not subject to the same quality controls as prescription medications, meaning contamination, mislabelling, or inconsistent dosing may occur
Rebalance: Build sustainable habits like stress management, better sleep, and improved diet